Further study is warranted to explore the precise mechanisms underlying the interplay between Cdc42, β-catenin, spike protein-mediated cellular senescence, and inflammatory response, and evaluate the therapeutic implications of targeting Cdc42 in the context of COVID-19 and other age-related diseases. The gene discussed is CDC42; the disease is COVID-19.